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 On the occasion of the 85th anniversary of its 
foundation, dermatovenereology as a teaching 
discipline in Zagreb was celebrated on November 
17, 2006 at University Department of Dermatology 
and Venereology, Zagreb University Hospital Cen-
ter and School of Medicine, organized by the Chair 
of Dermatology and Venereology, Zagreb School of 
Medicine. The event gathered renowned experts, 
led by Professor Nada Čikeš, Dean of the School 
of Medicine; Academician Željko Reiner, Direc-
tor of the Zagreb University Hospital Center and 
president of the Academy of Medical Sciences of 
Croatia; Professor Aleksej Kansky, past president 
of the Chair of Dermatovenereology (1980-1990); 
Professor Vladimira Barišić-Druško, actual presi-
dent of the Chair of Dermatovenereology, Osijek 
School of Medicine; Academician Dragan Dekaris 
from Croatian Academy of Sciences and Arts; and 
many prominent medical and pharmaceutical ex-
perts.
 The 85-year academic development of the 
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School of Medicine was presented by Professor 
Jasna Lipozenčić, actual head of the Chair. She 
emphasized enthusiastic efforts of prominent ex-
perts from the Zagreb School of Medicine hospital 
department who were involved in the develop-
ment of academic Croatian dermatovenereol-
ogy over time (Mašek, Šavnik, Kogoj, Čajkovac, 
Bošnjaković, Krajina, Brnobić, Kansky, Dobrić and 
Lipozenčić), that have resulted in the currently 
well recognized quality of dermatology and vene-
reology science and practice in modern Croatian 
medicine. 
 Professor Dobrić evoked the famous descrip-
tion of the spongiform pustule of Kogoj from 1927, 
an eponym named after him and distinguished 
from other pustular diseases.
 Dermatology and Venereology have been rec-
ognized as a teaching discipline, and the respec-
tive Chair has established its authority through 85 
years of work and endeavors of many internation-
ally renowned experts.
Prof. Jasna Lipozenčić, MD, PhD
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 This year’s EADV Congress venue Rhodos 
(October 3-8, 2006) welcomed nearly 6500 attend-
ees. It is near the homeland of Hippocrates (the is-
land of Kos), the “father of medicine” and Hellenis-
tic philosopher who has bequeathed some terms 
to dermatology, e.g., “alopecia” and “exanthema” 
as well as standard therapy for many centuries. 
The scientific program of the 15th EADV Congress 
was based on the pathophysiological mechanisms 
of skin diseases, as Hippocrates pleaded for un-
derstanding the suffering patient and his disease. 
 As Professor Johannes Ring, past President of 
EADV said, EADV has put special emphasis on 
the high level of postgraduate education. So, there 
were combined scientific sessions with young re-
searchers presenting original data in the form of 
poster or free communication, with courses and 
symposia devoted to education. Dermatologists 
in private practice benefited from the scientific 
program with due accounts of novel treatments, 
recipes, instruments and techniques to use them 
upon return to their office. What was special at the 
Rhodes EADV Congress?  Promising future: new 
techniques in molecular biology as well as new 
diagnostic/therapeutic tools in dermatology, such 
as polymerase chain reaction, protein and DNA 
microarrays, antibody based therapies; protein 
microarrays can be used for profiling of IgE an-
tibodies in the diagnosis of type-1 related allergic 
diseases; DNA-based methods to  investigate the 
genetic background of different dermatoses (e.g., 
in basal cell carcinoma, Darier’s disease, differ-
ent hair and nail disorders); there has been an 
exciting increase in the knowledge of the central 
role of the immune system in the pathogenesis of 
psoriasis; more specific, immunologically directed 
therapeutic strategies (biologicals) for psoriasis 
treatment have been developed (infliximab, etan-
ercept, efalizumab); nucleic acid based molecular 
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techniques have been introduced in the diagnosis 
of cancer as well; many studies have assessed 
the presence of tyrosinase mRNA by reverse tran-
scriptase polymerase chain reaction (RT-PCR) 
in peripheral blood from melanoma patients as 
a specific marker for circulating melanoma cells; 
infectious diseases represent an important health 
problem, especially because of the growing resis-
tance to the antibiotic treatment and photodynam-
ic therapy could be a viable alternative for skin 
infections (ALA plus visible light against yeasts 
and dermatophytes); treatment options of AIDS 
Kaposi’s sarcoma are increasing (antiretroviral 
therapy HAART), liposomal doxorubicin (20 mg/
m2 every 2-3 weeks), paclitaxel  (100 mg/m2 every 
two weeks), and irinotecan, matrix metalloprotein-
ase inhibitor (e.g., COL-3), herpetivirus G protein 
coupled receptor as a new therapeutic target for 
the treatment of Kaposi’s sarcoma; revisited and 
reclassified specific dermatoses of pregnancy 
(pemphigoid gestation (PG), polymorphic erup-
tion of pregnancy (PEP), intrahepatic cholestasis 
of pregnancy (ICP), atopic eruption of pregnancy 
(AEP); there is much evidence suggesting that the 
epidemic of atopic dermatitis  has stopped in parts 
of the western world; teleconsulting is relatively 
new in dermatology (videoconferences and store-
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and-forward-systems and images sent by e-mail or 
shared on a web-hosed system), but teledermatol-
ogy is changing the way of health service delivery 
and teleconsulting by specialized centers will be 
soon the gold standard of medical care; diagnos-
tic and therapeutic procedures in leukocytoclastic 
vacsulitis (LcV), (immune-complex-mediated LcV 
(corticosteroids, colchicin as a first line therapy in 
chronic or relapsing LcV and dapsone as a sec-
ond line therapy).
 As Professor Ring said: “Dermatovenereology 
faces presently a variety of challenges. The most 
actual themes of interest are skin cancer/oncology, 
allergy and  environmental hazards, infectious dis-
ease and “new venereology”, genetic dermatoses 
and skin hygiene with prevention of loss of skin 
functions including aesthetic dermatology, general 
dermatology with autoimmune and inflammatory 
disease (like psoriasis), always stays in the centre 
of our endeavours”.  
 During his two-year presidency, EADV 
achieved many things: new statutes, clear finan-
cial structure, the Academy moved to Switzerland, 
the EADV Board introduced new Task Forces on 
various and diverse areas of dermatovenereology, 
witnessed outstanding congresses like last year in 
London and two Spring Symposia in Sophia and 
in Saariselkä, and looking forward to the next big 
congress in Vienna (2007) and Spring Symposium 
in Istanbul (2008), had strong alliance with sister 
European societies of ESDR, EDF and UEMS 
in an European liaison committee, layer partner-
ship with ILDS and special welcoming the newly 
designated board members from countries of 
Eastern Europe (12 members, among them Prof. 
Lipozenčić from Croatia).
 Professor Andreas Katsambas, President of 
the 15th EADV Congress, made great effort for full 
success of the Congress, which it really proved 
to be. As the new EADV President, he will steer 
EADV successfully into the future.
   
  Prof. Jasna Lipozenčić, MD, PhD
    Acta Dermatovenerol Croat
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By winter sport use Nivea cream or oil; year 1935.
(from the collection of Mr. Zlatko Puntijar)
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 The management of chronic idiopathic urticaria 
(CIU) is very difficult. Decreased serum dehydro-
epiandrosterone (DHEA) and its sulfate derivative 
DHEA-S have been suggested to be important 
and involved in immune and inflammatory re-
sponses (1-3). We do not know whether lower se-
rum concentration of DHEA-S observed in CIU but 
not in healthy individuals is the cause or the effect 
of urticarial processes. It has been suggested that 
during inflammatory response, the adrenal steroid 
production is changed in the direction of cortisol 
relative to DHEA and DHEA-S (1,4). DHEA-S defi-
ciency is a feature of some autoimmune diseases 
that is also observed in CIU patients. Adrenal an-
drogens have been reported to exert immunoreg-
ulatory effects. As for now, we can only speculate 
about the role of DHEA-S deficiency in urticarial 
inflammation as a primary or secondary event in 
CIU.
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 The incidence of allergy has been increasing on 
our continent. One of four persons has or will have 
an allergic reaction. Nowadays, it is necessary to 
fight against environment, to pay due attention 
to social, occupational and family environment 
through training specialists and general practitio-
ners, educating patients by providing them with 
practical information on allergy, and to cope with 
hostile environment in order to upgrade the qual-
ity of life. The Supportive Initiative for the Global 
Management of Allergy (SIGMA) under the UCB 
Institute of Allergy (IOA) as an independent Eu-
ropean nonprofit organization established in 1987 
to combat allergy under the supervision of Scien-
tific Advisory Board made up of eminent European 
specialists in the field of allergy, is active in vari-
ous directions. SIGMA Meeting in Madrid was held 
on November 18, 2006, with experts in the field 
of scientific research in allergy as lecturers, who 
ACTIVITY OF THE SUPPORTIVE INITIATIVE  
FOR THE GLOBAL MANAGEMENT OF ALLERGY
Madrid, November 18, 2006
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held very interesting presentations: Are allergies 
today a global epidemic? (Adnan Čustović); Urti-
caria guidelines: reality and practicality (Alexander 
Kapp); and The links between rhinitis and asth-
ma (Pascal Demoly). There were workshops by 
countries, held by Todor Popov and presentations 
by country chairmen on their local action plans 
(Neven Tudorić from Croatia). The Croatian group 
(five specialists) took an active part in the meeting 
and proposed to organize five workshops in 2007 
in collaboration with IOA as well as conferences, 
to issue publications about allergy, and to promote 
research in the field of allergy. The Croatian IOA 
member group look forward to undertake activities 
within the SIGMA project in the future.
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